O
XENE icon

OppenheimerFunds’s Xenon Pharmaceuticals XENE Stock Holding History

OppenheimerFunds’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$173K Sell
16,998
-8,933
-34% -$75.7K ﹤0.01% 1722
2018
Q4 		$164K Sell
25,931
-2,836
-10% -$25.2K ﹤0.01% 1753
2018
Q3 		$380K Buy
28,767
+6,286
+28% +$72.8K ﹤0.01% 1556
2018
Q2 		$207K Buy
22,481
+11,476
+104% +$71.3K ﹤0.01% 1761
2018
Q1 		$54K Buy
+11,005
New +$40.7K ﹤0.01% 1770

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OppenheimerFunds's XENE Position: Q1 2019 in Review

OppenheimerFunds reduced its Xenon Pharmaceuticals (XENE) stake by 34% in Q1 2019, selling an estimated $75.7K and leaving 16,998 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #1722.

OppenheimerFunds first reported a position in XENE in Q1 2018 and has held it in 5 quarters since. The position peaked at $380K in Q3 2018. 63 funds tracked by Wall St. Rank hold XENE as of Q1 2019.

  • OppenheimerFunds held 16,998 shares of Xenon Pharmaceuticals worth $173K as of Q1 2019.
  • OppenheimerFunds sold 8,933 Xenon Pharmaceuticals shares in Q1 2019, an estimated $75.7K.
  • Xenon Pharmaceuticals made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1722 holding.
  • OppenheimerFunds first reported a position in Xenon Pharmaceuticals in Q1 2018 and has held it in 5 quarters since.
  • OppenheimerFunds's Xenon Pharmaceuticals position peaked at $380K in Q3 2018.
  • 63 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.